Viamet Pharmaceuticals, Inc.

Release Summary

Viamet announces the presentation of multiple studies supporting VT-1161, the Company’s lead product candidate for the treatment of fungal infections, at ASM Microbe 2017 in New Orleans, LA.

Viamet Pharmaceuticals, Inc.